Combining two multiple sclerosis treatments has no clinical benefit, study finds

BMJ 2013; 346 doi: (Published 14 March 2013) Cite this as: BMJ 2013;346:f1719
  1. Lilian Anekwe
  1. 1BMJ Evidence Centre

Combining glatiramer and interferon beta in patients with relapsing-remitting multiple sclerosis does not reduce symptoms or disability over three years, when compared with either treatment alone, a study has found.

The study, which was funded by the US National Institutes of Health, looked at the effects …

View Full Text

Log in

Log in through your institution


* For online subscription